Atg16 Antibodies

Santa Cruz Biotechnology provides a broad selection of Atg16 monoclonal antibodies for research in autophagy and cellular homeostasis. Atg16 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Atg16 plays a critical role in autophagosome formation, significantly impacting the autophagy process, which is essential for cellular degradation and recycling of components. The function of Atg16 is particularly important in maintaining cellular health and responding to stress conditions. Atg16 has emerged as a key player in various diseases, including cancer and neurodegenerative disorders. Research focusing on Atg16 continues to reveal new insights into cellular processes and potential therapeutic approaches. Understanding Atg16's mechanisms and interactions helps advance knowledge in cellular biology and disease treatment. Investigating Atg16's role in autophagy pathways provides valuable insights for developing targeted therapies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of autophagy and its impact on human health.